GLP-1 Compounding After Drug Shortages
Apothecary Pharma recalled 22 vials of compounded tirzepatide injections nationwide because of concerns about sterility, USA TODAY reported on October 19. The recall followed a…
DO
By Daniel Okafor · Regulatory Correspondent
Oct 31 00:20 ETSource: The Regulatory Review
From the source
Read at theregreview.orgGLP-1 Compounding After Drug Shortages
Apothecary Pharma recalled 22 vials of compounded tirzepatide injections nationwide because of concerns about sterility, USA TODAY reported on October 19. The recall followed a Food and Drug Administration (FDA) warning letter identifying substantial deficiencies in the pharmacy’s sterile-drug production practices. This incident reflects broader concerns about the safety of compounded glucagon-lik
